Elsevier

Biochemical Pharmacology

Volume 35, Issue 22, 15 November 1986, Pages 3971-3975
Biochemical Pharmacology

Immunochemical and functional characterization of UDP-glucuronosyltransferases from rat liver, intestine and kidney

https://doi.org/10.1016/0006-2952(86)90013-4Get rights and content

Abstract

Glucuronidation of various substrates in hepatic, intestinal and renal microsomes of control, phenobarbital (PB), 3-methylcholanthrene (3MC) and Aroclor-1254 (A1254) pretreated rats was investigated. UDPGT activities tested could be divided in four groups on the basis of their tissue distribution and induction by PB or 3MC in liver microsomes. GT1 activities (1-naphthol, benzo(a)pyrene-3,6-quinol) are induced by 3MC in liver microsomes and are present in all tissues investigated. GT2 activities (morphine, 4-hydroxybipheynl) are induced by PB in liver microsomes and appear to be restricted to the liver and the intestine. UDPGT activity towards bilirubin, although induced by PB, can be detected in hepatic, intestinal and renal microsomes. UDPGT activity towards fenoterol is restricted to the liver and intestine and is not induced by PB, 3MC or A1254.

The presence of inducible immunoreactive UDPGT isoenzymes in microsomes of liver, intestine and kidney of control and induced rats was demonstrated by immunoblot analysis using rabbit anti-rat liver-GT1 antibodies. Induction of both 54 and 56 kDa polypeptides in hepatic, intestinal and renal microsomes by 3MC or A1254 was observed. Purification of UDPGT (1-naphthol as substrate) from intestinal microsomes to apparent homogeneity yielded a polypeptide with an apparent molecular weight of 54–56 kDa.

The results indicate that 54 and 56 kDa UDPGT polypeptides are the major A1254 inducible isoenzymes in intestinal and renal microsomes. An increase in immunoreactive protein is correlated with a biochemically measurable increase in glucuronidation capacity for GT1 substrates.

References (36)

  • K.W. Bock et al.

    Biochem. Pharmac.

    (1980)
  • K.W. Bock et al.

    Biochem. Pharmac.

    (1983)
  • K.W. Bock et al.

    Biochim. biophys. Acta

    (1973)
  • W. Lilienblum et al.

    Biochem. Pharmac.

    (1982)
  • J.B. Watkins et al.

    Toxic. appl. Pharmac.

    (1982)
  • I. Scragg et al.

    FEBS Lett.

    (1985)
  • A.Sj. Koster et al.

    Biochem. Pharmac.

    (1983)
  • O.H. Lowry et al.

    J. biol. Chem.

    (1951)
  • A.Sj. Koster et al.

    Biochem. Pharmac.

    (1986)
  • C.M. Schiller et al.

    Chem. Biol. Interact.

    (1978)
  • G.F. Rush et al.

    Life Sci.

    (1984)
  • C.N. Falany et al.

    Arch Biochem. Biophys.

    (1983)
  • P.I. MacKenzie et al.

    Biochem. biophys. Res. Comm.

    (1984)
  • A. Aitio et al.
  • J. Roy Chowdhury et al.
  • C.N. Falany et al.
  • H. Pfeil et al.

    Eur. J. Biochem.

    (1982)
  • F.P. Guengerich et al.

    Biochemistry

    (1982)
  • Cited by (32)

    • Tissue-specific regulation of canine intestinal and hepatic phenol and morphine UDP-glucuronosyltransferases by β-naphthoflavone in comparison with humans

      2002, Biochemical Pharmacology
      Citation Excerpt :

      Quantitative comparison of hepatic and intestinal UGT activity is difficult, not the least because of different isolation procedures of intestinal microsomes. While dog intestinal microsomes were obtained from mucosal scrapings, human intestinal homogenates were obtained from enterocyte preparations, similar to previous studies with rat intestinal microsomes [25]. Interestingly, human hepatic and intestinal morphine UGT activities appear to be similar, in contrast to ca.10-fold higher hepatic and 10-fold lower intestinal activities in dogs and rats (Table 1).

    View all citing articles on Scopus

    This work was supported by a travel grant from the Netherlands Organization for the Advancement of Pure Research (Z.W.O.) to A. Sj. Koster. The results have been published in preliminary form: Naunyn-Schmiedebergs Archs Pharmac. 329, R17 (1985).

    View full text